Minireviews
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Sep 16, 2016; 8(17): 584-590
Published online Sep 16, 2016. doi: 10.4253/wjge.v8.i17.584
Table 1 Summary of recommendations for elective endoscopic procedure
Low-risk conditionsHigh-risk conditions
Low-risk proceduresContinue APA, warfarin and NOACContinue APA, warfarin and NOAC
Keep INR in therapeutic range in case of warfarinKeep INR in therapeutic range in case of warfarin
High-risk proceduresHold thienopyridines for 5 to 7 d before the procedure. Resume theonopyridine once hemostasis is obtained In case of dual APA, hold thienopyridines for 5 to 7 d before the procedure but continue aspirin Hold warfarin 5 d before the procedure. Resume warfarin on the same day as the procedure Hold NOAC: Rivaroxaban 2 to 4 d, apixaban 2 to 4 d, edoxaban 1 d and dabigatran 2 to 6 d before the procedure depending on creatinine clearance. Resume NOAC when adequate hemostasis is obtainedHold thienopyridines for 5 to 7 d before the procedure after discussion with the cardiologist. Resume theonopyridine once hemostasis is obtained In case of dual APA, hold thienopyridines for 5 to 7 d before the procedure but continue aspirin Delay endoscopic procedure if coronary artery stenting done and thienopyridines cannot be discontinued If the patient is on warfarin, bridge therapy with LMWH
Table 2 Summary of recommendations for emergency endoscopic procedures
AnticoagulantAPA
Active GI bleedHold the anticoagulantDo not stop thienopyridines without discussion with the
If on warfarin, give FFP, 4-factor PCC or IV Vitamin K to improve INRcardiologist in high risk situations like within 3 mo of ACS,
Avoid vitamin K in case of mechanical heart valvewithin 1 mo of placing a bare metal coronary stent and within
Hemodialysis in case of Dabigatran12 mo of placing a drug eluting coronary stent
Endoscopic therapy when INR is less than 2.5